<?xml version="1.0" encoding="UTF-8"?>
<iati-activities version="2.03">
 <iati-activity default-currency="EUR" hierarchy="1" iati-activities:version="2.03" xml:lang="EN" xmlns:iati-activities="http://d-portal.org/xmlns/iati-activities" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:noNamespaceSchemaLocation="http://iatistandard.org/203/schema/downloads/iati-activities-schema.xsd">
  <iati-identifier>NL-KVK-41207989-P-37203-2S4</iati-identifier>
  <reporting-org ref="NL-KVK-41207989" type="21">
   <narrative xml:lang="EN">Aidsfonds - Soa Aids Nederland</narrative>
  </reporting-org>
  <title>
   <narrative xml:lang="EN">Understanding the brain as a reservoir for HIV using novel stem cell technology to grow &#x2018;minibrains in a dish&#x2019;</narrative>
  </title>
  <description type="1">
   <narrative xml:lang="EN">Although we know that HIV can be found in the central nervous system (CNS) of most patients, we do not understand which cell types are infected by HIV in the CNS, how the CNS contributes to
the viral reservoir and how infection affects the brain and leads to HIV associated neurocognitive disorder (HAND). In this project we will set up an innovative culture model to gain more insight in these important questions. In our lab we grow cerebral organoids, also referred to as &#x2018;minibrains&#x2019;. These minibrains largely resemble the cell types and composition of real brain tissue. We will optimize how we can infect these minibrains with HIV, study which cells are infected by the virus and how this affects the function of these cells.</narrative>
  </description>
  <description type="3">
   <narrative xml:lang="EN">No patients will be directly affected by this study.</narrative>
  </description>
  <description type="4">
   <narrative xml:lang="EN">The HIV research community has been extensively working towards a cure for HIV, which is hampered by the fact that current HIV treatments do not eradicate HIV from the so-called HIV reservoirs.
The CNS is thought to represent an important HIV reservoir, comprising a unique micro-environment, cell composition and location behind the blood-brain-barrier. In addition, HIV-associated neurocognitive disorder (HAND) is still a major problem in the era of
cART. Mechanisms underlying HAND are poorly understood and besides cART, treatment strategies are lacking.</narrative>
  </description>
  <description type="2">
   <narrative xml:lang="EN">The aim of this study is to develop a valid human in vitro model to study HIV infection and related pathology of the brain. If our approach is successful this model can be used to increase our understanding of the target cell(s) of HIV in the brain, the characteristics of HIV infection and persistence in these cell types, how this reservoir can be reversed and which mechanisms underlie HAND. This kind of model will be extremely relevant for future treatment strategies towards reducing viral reservoirs and ultimately HIV cure as well as understanding and treatment of HAND.</narrative>
  </description>
  <participating-org ref="NL-KVK-41207989" role="1" type="22">
   <narrative xml:lang="EN">Aidsfonds Grants</narrative>
  </participating-org>
  <participating-org ref="NL-KVK-41207989" role="2" type="22">
   <narrative xml:lang="EN">Aidsfonds</narrative>
  </participating-org>
  <activity-status code="4"></activity-status>
  <activity-date iso-date="2019-01-01" type="2"></activity-date>
  <activity-date iso-date="2020-10-01" type="4"></activity-date>
  <contact-info type="1">
   <organisation>
    <narrative xml:lang="EN">Aidsfonds - Soa Aids Nederland</narrative>
   </organisation>
   <email>IATI@aidsfonds.nl</email>
   <website>https://aidsfonds.nl/</website>
   <mailing-address>
    <narrative xml:lang="EN">Aidsfonds - Soa Aids Nederland, Condensatorweg 54, 1014 AX Amsterdam</narrative>
   </mailing-address>
  </contact-info>
  <recipient-country code="NL" percentage="100"></recipient-country>
  <sector code="13040" percentage="100" vocabulary="1">
   <narrative xml:lang="EN">STD control including HIV/AIDS</narrative>
  </sector>
  <collaboration-type code="1"></collaboration-type>
  <default-flow-type code="30"></default-flow-type>
  <default-finance-type code="110"></default-finance-type>
  <default-aid-type code="C67" vocabulary="1"></default-aid-type>
  <default-tied-status code="5"></default-tied-status>
  <budget>
   <period-start iso-date="2019-01-01"></period-start>
   <period-end iso-date="2020-10-01"></period-end>
   <value currency="EUR" value-date="2019-01-01">75000</value>
  </budget>
  <transaction>
   <transaction-type code="11"></transaction-type>
   <transaction-date iso-date="2020-03-15"></transaction-date>
   <value currency="EUR" value-date="2020-03-15">75000</value>
   <provider-org provider-activity-id="NL-KVK-41207989-" ref="NL-KVK-41207989" type="22">
    <narrative xml:lang="EN">Aidsfonds Grants</narrative>
   </provider-org>
   <receiver-org ref="NL-KVK-30244197">
    <narrative xml:lang="EN">UMCU - Medical Microbiology, Virology</narrative>
   </receiver-org>
  </transaction>
  <transaction>
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2019-01-25"></transaction-date>
   <value currency="EUR" value-date="2019-01-25">67500</value>
   <provider-org ref="NL-KVK-41207989" type="22">
    <narrative xml:lang="EN">Aidsfonds Grants</narrative>
   </provider-org>
   <receiver-org ref="NL-KVK-30244197">
    <narrative xml:lang="EN">UMCU - Medical Microbiology, Virology</narrative>
   </receiver-org>
  </transaction>
  <transaction>
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-01-25"></transaction-date>
   <value currency="EUR" value-date="2019-01-25">67500</value>
   <provider-org ref="NL-KVK-41207989" type="22">
    <narrative xml:lang="EN">Aidsfonds Grants</narrative>
   </provider-org>
   <receiver-org ref="NL-KVK-30244197">
    <narrative xml:lang="EN">UMCU - Medical Microbiology, Virology</narrative>
   </receiver-org>
  </transaction>
  <transaction>
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2020-03-15"></transaction-date>
   <value currency="EUR" value-date="2020-03-15">7500</value>
   <provider-org ref="NL-KVK-41207989" type="22">
    <narrative xml:lang="EN">Aidsfonds Grants</narrative>
   </provider-org>
   <receiver-org ref="NL-KVK-30244197">
    <narrative xml:lang="EN">UMCU - Medical Microbiology, Virology</narrative>
   </receiver-org>
  </transaction>
  <related-activity ref="NL-KVK-41207989-P-10706-2S4KN" type="1"></related-activity>
 </iati-activity>
</iati-activities>
